Amneal Pharmaceuticals, Inc.
AMRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $111 | $92 | $26 | $248 |
| Short-Term Investments | $2 | $2 | $2 | $0 |
| Receivables | $776 | $646 | $742 | $695 |
| Inventory | $612 | $581 | $531 | $489 |
| Other Curr. Assets | $87 | $57 | $111 | $88 |
| Total Curr. Assets | $1,588 | $1,378 | $1,412 | $1,520 |
| Property Plant & Equip (Net) | $524 | $550 | $589 | $639 |
| Goodwill | $597 | $599 | $599 | $593 |
| Intangibles | $732 | $890 | $1,096 | $1,167 |
| Long-Term Investments | $36 | $37 | $86 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $24 | $18 | $18 | $21 |
| Total NC Assets | $1,914 | $2,095 | $2,388 | $2,420 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,501 | $3,473 | $3,799 | $3,940 |
| Liabilities | – | – | – | – |
| Payables | $260 | $144 | $167 | $131 |
| Short-Term Debt | $340 | $228 | $105 | $46 |
| Tax Payable | $0 | $0 | $0 | $3 |
| Deferred Revenue | $0 | $398 | $0 | $0 |
| Other Curr. Liab. | $530 | $77 | $481 | $498 |
| Total Curr. Liab. | $1,130 | $847 | $753 | $677 |
| LT Debt | $2,253 | $2,523 | $2,740 | $2,830 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $163 | $42 | $97 | $65 |
| Total NC Liab. | $2,416 | $2,565 | $2,838 | $2,895 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $107 | $110 | $123 | $127 |
| Total Liabilities | $3,546 | $3,411 | $3,590 | $3,573 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$607 | -$490 | -$406 | -$276 |
| AOCI | -$66 | -$32 | $10 | -$25 |
| Other Equity | $560 | $539 | $692 | $658 |
| Total Equity | -$109 | $20 | $298 | $360 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $65 | $42 | -$89 | $7 |
| Total Liab. & Tot. Equity | $3,501 | $3,473 | $3,799 | $3,940 |
| Net Debt | $2,483 | $2,659 | $2,819 | $2,628 |